Current research has illuminated the pivotal role of RNA m6A methyltransferase complex components, particularly METTL3 and METTL14, in the pathogenesis and progression of cancers, including acute myeloid leukemia (AML) (51) and hepatocellular carcinoma (HCC) (52). This evidence concerns the gene METTL3 and hepatocellular carcinoma.